Please assess the completion status of the following clinical trial:

Trial Title: Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Insulin detemir naive~* Type 1 diabetes for at least 12 months~* HbA1c lesser than or equal to 11.0%~Exclusion Criteria:~* Significant concomitant diseases

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- insulin detemir (Type: EXPERIMENTAL): insulin detemir + insulin aspart
- NPH insulin (Type: EXPERIMENTAL): NPH insulin + insulin aspart

Based on this trial design, predict the completion outcome and termination type (if applicable).